The SKYSCRAPER-01 study did not achieve its primary endpoint of overall survival for tiragolumab plus Tecentriq versus Tecentriq alone in PD-L1-high non-small cell lung cancer. The safety profile of ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A randomized phase 3 trial designed to evaluate ...
Squamous cell lung cancer starts in the squamous cells: thin, flat cells that line the inside of the airways in your lungs. If you're diagnosed after the cancer has spread, it tends to be more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results